| International Society for Applied Biological Sciences (ISABS)
"7th ISABS Conference in Forensic, Anthropologic and Medical Genetics and Mayo Clinic Lectures in Translational Medicine"
Bluesun hotel ELAPHUSA, Bol, Island of Brač, Croatia, June 20-24, 2011
For more information about invited speakers, please click here .
Prenatal diagnostics
Thursday, June 23 (Morning) - Workshop: Advances in Noninvasive Prenatal Diagnosis in First Trimester
"Non-Invasive Prenatal Diagnosis in the First Trimester – Isolation of Fetal Nucleated Red Blood via the CEP technology: Laboratory Aspects and Clinical Implementation"
Eliezer Shalev ● Human Genetic Center, Ha’emek Medical Center, Afula and Technion-Israel Institute of Technology, Haifa, Israel
Early Prenatal Diagnosis, An Overview
Ron Tepper ● Sapir Medical Center, Kfar Saba, Israel
Early Fetal 3D Ultrasound Examination
Stavit A. Shalev ● Human Genetic Center, Ha’emek Medical Center, Afula and Technion-Israel Institute of Technology, Haifa, Israel
Genetic approach in increased nuchal translucency and normal karyotype
Esther Guetta ● Danek Gertner Institute of Human Genetics, Sheba Medical Center, Tel-Hashomer, Israel
Free nucleic acids in maternal blood for noninvasive prenatal diagnosis
Simcha Yagel ● Hadassah Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel
First trimester screening for trisomy 21 with ultrasound and biochemical markers vs. fetal cell free nucleic acids in maternal serum
Ofer Klein ● Rebecca Sieff Medical Center and BioCep, Ltd., Safed, Israel
CEP as innovative method for isolation of fetal nucleated red blood cells for noninvasive prenatal diagnosis
Latest approaches in prenatal diagnosis and non-invasive prenatal diagnosis - a panel discussion regarding all aspects of prenatal diagnosis and recent advances in the field
Fetal cells and cell-free nucleic acids in maternal circulation as the basis for prenatal diagnosis. Pros and cons.
- The Cell Enrichment Process as an enabling tool in FNRBC isolation from maternal blood - including an audio-visual demonstration of the CEP in progress and result slides.
- Implementation of the CEP in prenatal diagnosis procedures - the complete process from separation to PCR of DNA.
- The benefits of early accurate diagnosis - the economic and clinical advantages of early diagnosis. The importance of expanding the reach of early stage testing and diagnosis via education and reimbursement. A panel discussion.
ESF Workshop on protein glycosylation in diagnostics and therapy
Thursday, June 23 (Afternoon) - Parallel Session: ESF Workshop on protein glycosylation in diagnostics and therapy
Nicolai Bovin ● Shemyakin & Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russian Federation
Diagnostic potential of antiglycan autoantibodies
Thierry Hennet ● Institute of Physiology, University of Zürich, Zürich, Switzerland
Congenital disorders of glycosylation, from genotypes to therapies
Gordan Lauc ● Faculty of Pharmacy and Biochemistry, University of Zagreb, Croatia
Complex genetics of protein glycosylation
Erdmann Rapp ● Max Planck Institute for Dynamic of Complex Technical Systems in Magdeburg, Germany
Tools for the glycome analysis in the post-genomic era
Manfred Wuhrer ● Leiden University Medical Center, Leiden, The Netherlands
Clinical glycomics of autoimmune diseases and cancer
Hakon Leffler ● Lund University Hopsital Sölvegatan, Lund, Sweden
Galectin binding glycoforms of serum proteins - a functional biomarker in cancer and inflammation
Biomathematical Modeling in Clinical Development of Dendritic Cell Cancer Immunotherapy
Monday, June 20 (Afternoon) - Parallel Session: Biomathematical Modeling and Cancer Immunotherapy 1
Stanimir Vuk-Pavlović ● College of Medicine, Mayo Clinic, Rochester, MN, USA
Impairment of cellular immunity in human cancer
Gunnar Kvalheim ● Norwegian Radium Hospital, University of Oslo, Oslo, Norway
Dendritic cell based cancer vaccines targeting tumor stem cells
Yuri Kogan ● Institute for Medical BioMathematics, Bene Ataroth, Israel
Improving alloreactive CTL immunotherapy for malignant gliomas using a mathematical model
Malcolm Brenner ● Baylor College of Medicine, Houston, TX, USA
Increasing safety and practicality of cell-based immunotherapy
Filippo Castiglione ● NRC Institute for Computing Applications, Rome, Italy
Mathematical modeling and optimal control of dendritic cell transfection cancer immunotherapy
Monday, June 21 (Afternoon) - Parallel Session: Biomathematical Modeling and Cancer Immunotherapy 2
Moran Elishmereni ● Institute for Medical BioMathematics, Bene Ataroth, Israel
A validated mathematical model of systemic IL-21 immunotherapy in solid cancers for the design of beneficial treatment regimens
Zwi Berneman ● University of Antwerp, Antwerp, Belgium
Dendritic cell vaccination in leukemia and AIDS
Karin HaLevi ● Institute for Medical BioMathematics, Bene Ataroth, Israel
A method for in-treatment personalization of cancer immunotherapy
Samuel Volchenboum ● University of Chicago, Chicago, IL, USA
New systems biology tools for cancer diagnostics
Stipan Jonjić ● Faculty of Medicine, University of Rijeka, Rijeka, Croatia
How viruses can teach us to make better vaccines and vaccine vectors
Legislation pertinent to DNA databases
Tuesday, June 23 (Morning) - Parallel Session: Forensic Science 2
Dragan Primorac ● University of Split, University of Osijek, Croatia, The Pennsylvania State University, USA
From dust to dust: Forensic DNA analysis
Mitchell Holland ● Eberly College of Science, Penn State University, PA, USA
Interpretation of STR mixtures
Sree Kanthaswamy ● California National Primate Research Center, University of California, Davis, CA, USA
Non-human forensic genetics
Marilyn Menotti-Raymond ● National Cancer Institute, Frederick, MD, USA
Genetics of coat patterns in the domestic cat
Antti Sajantila ● University of Helsinki, Helsinki, Finland
Post mortem pharmacogenomics - concepts, cases and research
|
